The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. (Q47194413)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 August 2017

edit

Language	Label	Description	Also known as
English	The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.	scientific article published on 14 August 2017

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

title

The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

main subject

weight gain

1 reference

based on heuristic

inferred from title

author name string

Caleb C Lord

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Steven C Wyler

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Rong Wan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Carlos M Castorena

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Newaz Ahmed

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Dias Mathew

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Syann Lee

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Chen Liu

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

Joel K Elmquist

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

language of work or name

English

0 references

publication date

14 August 2017

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

published in

Journal of Clinical Investigation

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

volume

127

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

issue

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

page(s)

3402-3406

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

cites work

Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Antipsychotic medications: metabolic and cardiovascular risk

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

27 July 2018

Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669575

retrieved

14 August 2018

Identifiers

DOI

10.1172/JCI93362

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

PMC publication ID

5669575

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

PubMed publication ID

28805659

1 reference

stated in

Europe PubMed Central

PMC publication ID

5669575

retrieved

19 July 2018

reference URL

http://europepmc.org/abstract/PMC/5669575

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47194413&oldid=2116745145"